HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 920771Erstellt: 25. Oktober 2026
Toluene → 2-(3-Chloro-4-fluorophenyl)-N5-(3,3-dimethylcyclobutyl)-6,7-dihydropyrazolo[1,5-a]pyrazine-3,5(4H)-dicarboxamide
https://huagongshe.com/reaction/920771
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Toluene | HCID 1140 | — |
| Edukt | P,P-Diphenylphosphinic azide | HCID 199401 | — |
| Edukt | 3,3-Dimethylcyclobutanecarboxylic acid | HCID 215106 | — |
| Edukt | 2-(3-Chloro-4-fluorophenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-3-carboxamide | HCID 118061627 | — |
| Lösungsmittel | Dimethylformamide | HCID 6228 | — |
| Produkt | 2-(3-Chloro-4-fluorophenyl)-N5-(3,3-dimethylcyclobutyl)-6,7-dihydropyrazolo[1,5-a]pyrazine-3,5(4H)-dicarboxamide | HCID 118062851 | 46% |
Reaktionsschritte
To a stirred solution of Intermediate 285D (13 mg, 0.1 mmol) in toluene (2 ml) was added TEA (0.071 ml, 0.509 mmol), DPPA (0.028 ml, 0.122 mmol) and the reaction mixture was heated to 90° C. for 1 h. The reaction mixture was cooled to RT and to it was added a solution of Intermediate 185B (30 mg, 0.102 mmol) in DMF (1 mL) and stirred at RT for 16 h. The reaction mixture was quenched with 10% NaHCO3 and extracted with ethyl acetate (2×20 mL). The combined organic layer was dried over Na2SO4, filtered and the filtrate evaporated under reduced pressure. The crude product was purified by preparative HPLC to afford Compound 285 (20 mg, 46%). HPLC retention times 9.40 min. and 8.50 min (Methods A and B respectively). MS(ES): m/z=420 [M+H]+; 1H NMR (400 MHz, DMSO-d6) δ ppm 7.81-7.90 (m, 1H), 7.64-7.74 (m, 1H), 7.42-7.46 (m, 1H), 7.14-7.40 (d, 2H), 6.98 (s, 1H), 4.72 (s, 2H), 4.06-4.20 (m, 3H), 3.82 (t, J=5.27 Hz, 2H), 1.95-2.05 (m, 2H), 1.72-1.83 (m, 2H), 1.11 (d, J=7.53 Hz, 6H).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US09273058B2 |
|---|
| Quelldatensatz | uspto-grants-2016_03 |
|---|
| ORD ID | ord-20b3f2a2b39b406793ae5de6d2dfd515 |
|---|
| Quellennotiz | uspto-grants-2016_03 |
|---|